Recurrence risk model for esophageal cancer after radical surgery
- PMID: 24255579
- PMCID: PMC3828437
- DOI: 10.3978/j.issn.1000-9604.2013.10.05
Recurrence risk model for esophageal cancer after radical surgery
Abstract
Objective: The aim of the present study was to construct a risk assessment model which was tested by disease-free survival (DFS) of esophageal cancer after radical surgery.
Methods: A total of 164 consecutive esophageal cancer patients who had undergone radical surgery between January 2005 and December 2006 were retrospectively analyzed. The cutpoint of value at risk (VaR) was inferred by stem-and-leaf plot, as well as by independent-samples t-test for recurrence-free time, further confirmed by crosstab chi-square test, univariate analysis and Cox regression analysis for DFS.
Results: The cutpoint of VaR was 0.3 on the basis of our model. The rate of recurrence was 30.3% (30/99) and 52.3% (34/65) in VaR <0.3 and VaR ≥0.3 (chi-square test, (χ) (2) =7.984, P=0.005), respectively. The 1-, 3-, and 5-year DFS of esophageal cancer after radical surgery was 70.4%, 48.7%, and 45.3%, respectively in VaR ≥0.3, whereas 91.5%, 75.8%, and 67.3%, respectively in VaR <0.3 (Log-rank test, (χ) (2) =9.59, P=0.0020), and further confirmed by Cox regression analysis [hazard ratio =2.10, 95% confidence interval (CI): 1.2649-3.4751; P=0.0041].
Conclusions: The model could be applied for integrated assessment of recurrence risk after radical surgery for esophageal cancer.
Keywords: Esophageal cancer; model; radical surgery; recurrence.
Figures
Similar articles
-
Recurrence and prognostic model for identifying patients at risk for esophageal cancer after surgery.Cancer Manag Res. 2018 Nov 21;10:6109-6120. doi: 10.2147/CMAR.S186194. eCollection 2018. Cancer Manag Res. 2018. PMID: 30538559 Free PMC article.
-
A novel preoperative plasma indicator to predict prognoses for patients with esophageal squamous cell carcinoma after radical esophagectomy: fibrinogen-to-lymphocyte ratio.Cancer Manag Res. 2019 May 23;11:4719-4728. doi: 10.2147/CMAR.S204938. eCollection 2019. Cancer Manag Res. 2019. PMID: 31213896 Free PMC article.
-
[Value of preoperative abdominal contrast-enhanced multiple-row detector computed tomography in predicting the postoperative 1-year disease-free survival for gastric cancer].Zhonghua Wei Chang Wai Ke Za Zhi. 2018 Sep 25;21(9):1059-1064. Zhonghua Wei Chang Wai Ke Za Zhi. 2018. PMID: 30269328 Chinese.
-
The Impact of Postoperative Conformal Radiotherapy after Radical Surgery on Survival and Recurrence in Pathologic T3N0M0 Esophageal Carcinoma: A Propensity Score-Matched Analysis.J Thorac Oncol. 2017 Jul;12(7):1143-1151. doi: 10.1016/j.jtho.2017.03.024. Epub 2017 Apr 12. J Thorac Oncol. 2017. PMID: 28411098
-
A meta-analysis on surgery with or without postoperative radiotherapy to treat squamous cell esophageal carcinoma.Int J Surg. 2020 Aug;80:184-191. doi: 10.1016/j.ijsu.2020.06.046. Epub 2020 Jul 10. Int J Surg. 2020. PMID: 32659390 Review.
Cited by
-
Genome-Wide DNA Methylation and Gene Expression Profiling Characterizes Molecular Subtypes of Esophagus Squamous Cell Carcinoma for Predicting Patient Survival and Immunotherapy Efficacy.Cancers (Basel). 2022 Oct 11;14(20):4970. doi: 10.3390/cancers14204970. Cancers (Basel). 2022. PMID: 36291754 Free PMC article.
-
Recurrence and prognostic model for identifying patients at risk for esophageal cancer after surgery.Cancer Manag Res. 2018 Nov 21;10:6109-6120. doi: 10.2147/CMAR.S186194. eCollection 2018. Cancer Manag Res. 2018. PMID: 30538559 Free PMC article.
-
The Relationship between Social Support and Quality of Life: Evidence from a Prospective Study in Chinese Patients with Esophageal Carcinoma.Iran J Public Health. 2015 Dec;44(12):1603-12. Iran J Public Health. 2015. PMID: 26811811 Free PMC article.
-
Postoperative Radiotherapy in Curatively Resected Esophageal Squamous Cell Carcinoma With Occult Recurrent Laryngeal Nerve Lymph Node Metastasis.Cancer Control. 2024 Jan-Dec;31:10732748241285142. doi: 10.1177/10732748241285142. Cancer Control. 2024. PMID: 39259654 Free PMC article.
-
Patterns of recurrence after surgery and efficacy of salvage therapy after recurrence in patients with thoracic esophageal squamous cell carcinoma.BMC Cancer. 2020 Feb 22;20(1):144. doi: 10.1186/s12885-020-6622-0. BMC Cancer. 2020. PMID: 32087687 Free PMC article.
References
-
- Kleinberg L, Forastiere AA. Chemoradiation in the management of esophageal cancer. J Clin Oncol 2007;25:4110-7 - PubMed
-
- Hulscher JB, van Sandick JW, Tijssen JG, et al. The recurrence pattern of esophageal carcinoma after transhiatal resection. J Am Coll Surg 2000;191:143-8 - PubMed
-
- Mariette C, Balon JM, Piessen G, et al. Pattern of recurrence following complete resection of esophageal carcinoma and factors predictive of recurrent disease. Cancer 2003;97:1616-23 - PubMed
-
- Chen G, Wang Z, Liu XY, et al. Recurrence pattern of squamous cell carcinoma in the middle thoracic esophagus after modified Ivor-Lewis esophagectomy. World J Surg 2007;31:1107-14 - PubMed
-
- Lu JC, Kong C, Tao H. Radiotherapy with or without concurrent chemotherapy for lymph node recurrence after radical surgery of thoracic esophageal squamous cell carcinoma. Int J Radiat Oncol Biol Phys 2010;78:710-4 - PubMed
LinkOut - more resources
Full Text Sources